D-Index & Metrics Best Publications

Mario Mercuri

University of Bologna
Italy

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Medicine D-index 73 Citations 15,703 288 World Ranking 16001 National Ranking 604

Overview

What is he best known for?

The fields of study Mario Mercuri is best known for:

Solvatochromism
Chromophore
Catalysis

Mario Mercuri combines Organic chemistry and Combinatorial chemistry in his research. Mario Mercuri brings together Combinatorial chemistry and Organic chemistry to produce work in his papers. His Dissolution study typically links adjacent topics like Chemical engineering. His Chemical engineering study frequently links to other fields, such as Dissolution. Mario Mercuri integrates several fields in his works, including Reagent and Catalysis. His work blends Catalysis and Reagent studies together. Hyperpolarizability and Polarizability are frequently intertwined in his study. His Polarizability study frequently draws connections between related disciplines such as Hyperpolarizability. His Photochemistry study frequently draws connections between related disciplines such as Chromophore.

His most cited work include:

Square-planar d8 metal mixed-ligand dithiolene complexes as second order nonlinear optical chromophores: Structure/property relationship (120 citations)
Pd-Dissolution through a mild and effective one-step reaction and its application for Pd-recovery from spent catalytic converters (40 citations)

What are the main themes of his work throughout his whole career to date

With his scientific publications, his incorporates both Organic chemistry and Combinatorial chemistry. Mario Mercuri conducts interdisciplinary study in the fields of Combinatorial chemistry and Organic chemistry through his works. Crystallography and Isostructural are commonly linked in his work. In his works, Mario Mercuri undertakes multidisciplinary study on Isostructural and Crystal structure. Mario Mercuri merges many fields, such as Crystal structure and Triclinic crystal system, in his writings. His work in Triclinic crystal system is not limited to one particular discipline; it also encompasses Crystallography. Mario Mercuri connects Molecule with Stereochemistry in his research. Mario Mercuri merges many fields, such as Stereochemistry and Molecule, in his writings. His Biochemistry study frequently links to other fields, such as Solvatochromism.

Mario Mercuri most often published in these fields:

Organic chemistry (100.00%)
Crystallography (70.00%)
Molecule (70.00%)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Primary bone osteosarcoma in the pediatric age: State of the art

Alessandra Longhi;Costantino Errani;Massimiliano De Paolis;Mario Mercuri.
Cancer Treatment Reviews (2006)

666 Citations

Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution.

Gaetano Bacci;Alessandra Longhi;Michela Versari;Mario Mercuri.
Cancer (2006)

629 Citations

Platelet-derived growth factors enhance proliferation of human stromal stem cells.

Enrico Lucarelli;Amira Beccheroni;Davide Donati;Luca Sangiorgi.
Biomaterials (2003)

569 Citations

Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.

Stefano Ferrari;Sigbjorn Smeland;Mario Mercuri;Franco Bertoni.
Journal of Clinical Oncology (2005)

519 Citations

Failure mode classification for tumor endoprostheses: retrospective review of five institutions and a literature review

Eric R. Henderson;John S. Groundland;Elisa Pala;Jeremy A. Dennis.
Journal of Bone and Joint Surgery, American Volume (2011)

513 Citations

Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin

Gaetano Bacci;Piero Picci;Stefano Ferrari;Pietro Ruggieri M.D..
Cancer (1993)

389 Citations

Giant cell tumor of the extremity: A review of 349 cases from a single institution.

Costantino Errani;Pietro Ruggieri;Marco Antonio Nogales Asenzio;Angelo Toscano.
Cancer Treatment Reviews (2010)

345 Citations

Postrelapse Survival in Osteosarcoma of the Extremities: Prognostic Factors for Long-Term Survival

Stefano Ferrari;Antonio Briccoli;Mario Mercuri;Franco Bertoni.
Journal of Clinical Oncology (2003)

340 Citations

A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study

G Grignani;Emanuela Palmerini;P. Dileo;S. D. Asaftei.
Annals of Oncology (2012)

313 Citations

Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities the istituto rizzoli experience in 127 patients treated preoperatively with intravenous methotrexate (high versus moderate doses) and intraarterial cisplatin

G. Bacci;P. Picci;P. Ruggieri;M. Mercuri.
Cancer (1990)

305 Citations

If you think any of the details on this page are incorrect, let us know.